Remove Healthcare Remove Life Sciences Remove Pharmaceuticals Remove Telemedicine
article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Key Trends and Market Summary. from $34.61

article thumbnail

Digiceuticals: Driving Growth Through Digital Health Services

HIT Consultant

Subhro Mallik, SVP & Head of Life Sciences at Infosys. There was tremendous interest in telemedicine before 2020. For instance, digital-first healthcare aggregators had been testing programs for telemedicine but, since 2020, the demand for telehealth services has exploded across the globe.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Impact of India’s New Privacy Law on Healthcare

Triage Health Law

billion, healthcare and associated sectors such as life sciences and insurance are key elements both of India’s economy and of the central government’s social policy agenda. However, sensitive healthcare and insurance data is an attractive target for cyberattacks including ransomware and denial of service.

article thumbnail

The Desire for Cost Savings Driving Key Trends in Healthcare Market

HIT Consultant

John Calcagnini, Managing Director of Healthcare & Life Sciences at Stout. However, payers are working to reduce the cost of care to reel in healthcare costs and keep premiums lower to remain competitive, driving key changes. Healthcare payers are looking to align reimbursement with patient outcomes.

article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. PPP in the US), and in emerging markets, currency weakness. spends on NASA.

article thumbnail

Taking the Pulse on eCME – What’s Next for Continued Medical Education

HIT Consultant

Over the past two years, we’ve witnessed the massive digital disruption in healthcare that was spurred by the pandemic. Just consider the conferences that once used to draw large crowds of physicians seeking to attain their continuing medical education (CME) requirements.

article thumbnail

Enabling better health care, everywhere – my conversation with Microsoft

Health Populi

Key opinion leader Molly McCarthy and I covered a lot of ground in this webcast conversation as part of Microsoft’s series of three “Expert perspectives on trends driving change in healthcare.” Thanks to Microsoft for its leadership in enabling better healthcare, everywhere.